-
Nasdaq will delist Windtree Therapeutics for stock price noncompliance.
-
Shares have dropped over 90% in a month, now at $0.11.
-
The firm recently invested heavily in BNB tokens.
Delisting Notice
Windtree Therapeutics, a digital asset treasury company, will be delisted from Nasdaq after failing to keep its stock price above $1. The suspension starts August 21.
Stock Crash
Windtree’s stock has collapsed more than 99% this year, driven by sharp sell-offs despite attempts to raise funds through equity deals. The company confirmed Nasdaq’s concerns in an SEC filing.
Crypto Treasury Moves
Earlier this year, Windtree invested heavily in BNB tokens, one of the first public U.S. companies to do so. The move attracted attention but ultimately failed to support its stock.
Wider Sector Pressure
Other digital asset treasury companies have also seen steep declines, raising questions about the model. Meanwhile, BNB itself has risen nearly 5% to $877.
